T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579751/
https://www.ncbi.nlm.nih.gov/pubmed/34773893
http://dx.doi.org/10.1016/j.ebiom.2021.103692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579751/
https://www.ncbi.nlm.nih.gov/pubmed/34773893
http://dx.doi.org/10.1016/j.ebiom.2021.103692

Ejemplares similares